Trade MEDS anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
DataMeds AI, Inc. (MEDS) is trading at US$0.96, down 17.90% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$4.19M. Over the past 52 weeks, MEDS has traded between US$0.96 and US$86.00. On Syfe you can trade MEDS with $0 commission and add it to your watchlist.
| Previous close | US$1.17 |
|---|---|
| Market cap | US$4.19M |
| 52-week range | US$0.96 – US$86.00 |
| Volume | 123.9K |
| Exchange | US |
Add to Watchlist
Set Price Alert
DataMeds AI, Inc.
DataMeds AI, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. Its business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.
Year: 2025
DataMeds AI, Inc. (MEDS) stock is trading at US$0.96, -17.90% from the previous close of US$1.17.
The market cap for DataMeds AI, Inc. (MEDS) stock is approximately US$4.19M.
The 52-week high for DataMeds AI, Inc. (MEDS) stock is US$86.00.
The 52-week low for DataMeds AI, Inc. (MEDS) stock is US$0.96.
DataMeds AI, Inc. (MEDS) does not currently pay a dividend.
Stay on top of MEDS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
